example 131 [WO2009133348]   Click here for help

GtoPdb Ligand ID: 8489

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is claimed in patent WO2009133348 [1]. WO2009133348 reports the development of human tissue kallikrein (KLK1) inhibitors, and covers their use for the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 100.35
Molecular weight 431.21
XLogP 2.1
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CCN1CCCC1C(=O)NC(C(=O)NCc1ccc(nc1)N)Cc1ccc(c(c1)F)F
Isomeric SMILES CCN1CCC[C@@H]1C(=O)N[C@H](C(=O)NCc1ccc(nc1)N)Cc1ccc(c(c1)F)F
InChI InChI=1S/C22H27F2N5O2/c1-2-29-9-3-4-19(29)22(31)28-18(11-14-5-7-16(23)17(24)10-14)21(30)27-13-15-6-8-20(25)26-12-15/h5-8,10,12,18-19H,2-4,9,11,13H2,1H3,(H2,25,26)(H,27,30)(H,28,31)/t18-,19+/m0/s1
Immunopharmacology Disease
Disease X-Refs Comment References
Asthma Disease Ontology: DOID:2841
OMIM: 600807
A compound developed with predicted clinical utility in asthma.
Chronic obstructive pulmonary disease Disease Ontology: DOID:3083
A compound developed with predicted clinical utility in COPD.